A3EP67 fundamentals
An in-depth look to FibroBiologics, Inc. operating, investing, and financing activities
A3EP67 free cash flow for Q3 24 is -2.35 M EUR. For 2023, A3EP67 free cash flow was -6.25 M EUR and operating cash flow was -5.8 M EUR.
Q3 '22
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM